Last $35.78 USD
Change Today +0.29 / 0.82%
Volume 372.8K
ABMD On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

abiomed inc (ABMD) Snapshot

Open
$35.58
Previous Close
$35.49
Day High
$36.37
Day Low
$35.31
52 Week High
11/26/14 - $36.37
52 Week Low
05/8/14 - $20.29
Market Cap
1.5B
Average Volume 10 Days
455.1K
EPS TTM
$0.31
Shares Outstanding
40.9M
EX-Date
--
P/E TM
115.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for ABIOMED INC (ABMD)

Related News

No related news articles were found.

abiomed inc (ABMD) Related Businessweek News

No Related Businessweek News Found

abiomed inc (ABMD) Details

ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor program. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.

511 Employees
Last Reported Date: 05/28/14
Founded in 1981

abiomed inc (ABMD) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $519.7K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $315.9K
Chief Operating Officer
Total Annual Compensation: $341.8K
Vice President and General Manager of Global ...
Total Annual Compensation: $297.0K
Senior Vice President of Global Product Opera...
Total Annual Compensation: $284.6K
Compensation as of Fiscal Year 2014.

abiomed inc (ABMD) Key Developments

ABIOMED, Inc. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-20-2014 10:40 AM

ABIOMED, Inc. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-20-2014 10:40 AM. Venue: The Waldorf Hilton, Aldwych, London, United Kingdom. Speakers: Robert L. Bowen, Chief Financial Officer, Principal Accounting Officer, Vice President and Treasurer.

ABIOMED, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2014; Reiterates Earnings Guidance for the Fiscal Year 2015

ABIOMED, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported net income of $3,839,000 or $0.09 per diluted share compared to $1,059,000 or $0.03 per diluted share for the same period last year. Income before provision for income taxes was $4,175,000 compared to $1,429,000 for the same period last year. Income from operations was $4,178,000 compared to $1,398,000 for the same period last year. Total revenue was $51,938,000 compared to $44,345,000 for the same period last year. For the nine months, the company reported net income of $2,130,000 or $0.05 per diluted share compared to net loss of $664,000 or $0.02 per diluted share for the same period last year. Income before provision for income taxes was $2,692,000 compared to $117,000 for the same period last year. Income from operations was $2,640,000 compared to $91,000 for the same period last year. Total revenue was $100,749,000 compared to $87,015,000 for the same period last year. The company reiterated earnings guidance for the fiscal year 2015. For the period, the company is increasing the lower end of its revenue guidance with the new range of $209 million to $212 million from the original range of $205 million to $212 million. The company is reiterating its fiscal year 2015 guidance for GAAP operating margin of 1% to 4%.

ABIOMED, Inc. Presents at Stephens Inc. Fall Investment Conference 2014, Nov-11-2014 10:00 AM

ABIOMED, Inc. Presents at Stephens Inc. Fall Investment Conference 2014, Nov-11-2014 10:00 AM. Venue: New York Palace Hotel, 455 Madison Avenue, New York, New York, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABMD:US $35.78 USD +0.29

ABMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $18.86 USD +0.32
LeMaitre Vascular Inc $7.50 USD +0.23
Spectranetics Corp/The $32.29 USD +0.29
Thoratec Corp $31.10 USD -0.17
Volcano Corp $11.34 USD +0.05
View Industry Companies
 

Industry Analysis

ABMD

Industry Average

Valuation ABMD Industry Range
Price/Earnings 100.0x
Price/Sales 7.3x
Price/Book 8.2x
Price/Cash Flow 144.2x
TEV/Sales 6.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABIOMED INC, please visit www.abiomed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.